Columbia Laboratories, Inc.

Providing specialty pharmaceuticals that treat infertility and other women’s healthcare conditions in a targeted, patient-friendly way.

Home

About Us

Our Vision & Goals

Management Team

Board of Directors

Strategic Alliances

Our Products

Research and Development

Drug Delivery Technology

Investor Relations

Contact Us

Contact Form

Driving Directions & Map

For Investors
This website contains forward-looking statements about Columbia Laboratories, Inc.’s expectations regarding the Company’s strategic direction, prospects and future results, and clinical research programs. These statements are indicated by the words "will," "plan," "expect" and similar expressions.  Such forward-looking statements are subject to certain risks and uncertainties; actual results may differ materially from those projected in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. Factors that might cause future results to differ include, but are not limited to, the following: the successful marketing of CRINONE® 8% (progesterone gel), PROCHIEVE® 8% (progesterone gel), PROCHIEVE 4% (progesterone gel), and STRIANT® (testosterone buccal system) in the U.S.; the timely and successful development of new products, including  PROCHIEVE 8% to reduce the risk of preterm birth in women with a short cervix at mid-pregnancy; the timely and successful completion of clinical studies, including the clinical studies for our vaginally-administered vaginal lidocaine product candidate; success in obtaining acceptance and approval of new products and new indications for current products by the FDA and international regulatory agencies, the impact of competitive products and pricing; competitive economic and regulatory factors in the pharmaceutical and healthcare industry; general economic conditions; and other risks and uncertainties that may be detailed, from time-to-time, in Columbia’s reports filed with the Securities and Exchange Commission. Columbia Laboratories undertakes no obligation to publicly update any forward-looking statements.
Further, the Company’s investor relations website incorporates data that the Company provides as a convenience for stockholders. These data are for informational purposes only, and are not intended, and should not be relied upon, for trading purposes. Neither the Company nor its data providers guarantee the accuracy or completeness of any stock price or other data displayed, nor shall any such party be liable in any way to the user of the data or to any other person for any delays, inaccuracies, errors in or omission of any such data or the transmission thereof, or for any actions taken in reliance thereon or for any damages arising there from or occasioned thereby. Investors are reminded that historical and current stock price performance data are not necessarily indicative of future performance.

Click I Agree to enter the CBRX Investor Relations website


Legal  |  Glossary |  Site Map

Copyright 2007 Columbia Laboratories, Inc., All Rights Reserved.